Gastrointestinal

Significant reduction seen in VTE rates, with similar reductions for patients with and without obesity

Findings based on wearable-collected, real-world data, independent of clinical and genetic risk factors

Most common adverse events related to surgical procedures, adverse drug events, health care-associated infections

Increased risk for developing any dyslipidemia seen during 2020 to 2022

Fasting shows benefits compared with eating meals or snacks at night

In recent study, 25 of 55 controlled ovarian hyperstimulation cycles had complications

Findings show up to 70 percent increased risk for offspring at ages 1, 2, and 3 years

Fourteen of 18 patients had neoantigen-specific T-cell responses; recurrence-free survival was 87.5 percent at 36 months

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction

Significant declines seen across genders, races/ethnicities

Model shows good performance using only electronic health record data

From 2000 to 2019, definitive treatment for those with intermediate- or high-risk disease and limited life expectancy increased

Mean time to relapse also longer for those undergoing ultrasonic propulsion

Dementia death rates stable between 2018 and 2019, then increased in 2020, and declined in 2022, with the rate higher than 2018, 2019

In multivariable analyses after adjustment for demographics and smoking status, odds ratio was 2.21 for eczema in areas with higher PM2.5